Titan Pharmaceuticals (NASDAQ:TTNP) Now Covered by Analysts at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Free Report) in a note issued to investors on Tuesday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance Shares of Titan Pharmaceuticals stock opened at $4.42 on Tuesday. The business’s 50 day moving […]
